ArticleBreast cancer research : BCR2025

MSN/STAT3 drives cancer stemness and chemoresistance via IL-6/LPAR1 ligand receptor complex in triple-negative breast cancer.

Cheng Hyun Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.